NRXS
Price
$6.99
Change
-$0.02 (-0.29%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
90.9M
Intraday BUY SELL Signals
PCVX
Price
$46.97
Change
-$0.44 (-0.93%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
6.85B
70 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRXS vs PCVX

Header iconNRXS vs PCVX Comparison
Open Charts NRXS vs PCVXBanner chart's image
NRXS vs PCVX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NRXS vs. PCVX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXS is a Hold and PCVX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (NRXS: $7.01 vs. PCVX: $47.42)
Brand notoriety: NRXS and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXS: 142% vs. PCVX: 98%
Market capitalization -- NRXS: $90.9M vs. PCVX: $6.85B
NRXS [@Biotechnology] is valued at $90.9M. PCVX’s [@Biotechnology] market capitalization is $6.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXS’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • NRXS’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, both NRXS and PCVX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXS’s TA Score shows that 3 TA indicator(s) are bullish while PCVX’s TA Score has 5 bullish TA indicator(s).

  • NRXS’s TA Score: 3 bullish, 7 bearish.
  • PCVX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than NRXS.

Price Growth

NRXS (@Biotechnology) experienced а +0.14% price change this week, while PCVX (@Biotechnology) price change was -5.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

PCVX is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($6.85B) has a higher market cap than NRXS($90.9M). NRXS YTD gains are higher at: 54.405 vs. PCVX (2.774). NRXS has higher annual earnings (EBITDA): -7.12M vs. PCVX (-1.06B). PCVX has more cash in the bank: 1.74B vs. NRXS (7.08M). NRXS has less debt than PCVX: NRXS (354K) vs PCVX (116M). NRXS has higher revenues than PCVX: NRXS (4.28M) vs PCVX (0).
NRXSPCVXNRXS / PCVX
Capitalization90.9M6.85B1%
EBITDA-7.12M-1.06B1%
Gain YTD54.4052.7741,961%
P/E RatioN/AN/A-
Revenue4.28M0-
Total Cash7.08M1.74B0%
Total Debt354K116M0%
FUNDAMENTALS RATINGS
PCVX: Fundamental Ratings
PCVX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
47
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRXSPCVX
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 29 days ago
86%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
NRXS
Daily Signal:
Gain/Loss:
PCVX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUTHX26.72N/A
N/A
Franklin Mutual Shares Z
SLCVX26.87N/A
N/A
Saratoga Large Capitalization Value I
GCCSX35.96N/A
N/A
Gabelli Small Cap Growth C
CAPRX9.71N/A
N/A
Federated Hermes Capital Income R
PVCIX12.45N/A
N/A
Palm Valley Capital Institutional

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
-4.50%
CVM - NRXS
58%
Loosely correlated
+0.68%
ANRO - NRXS
26%
Poorly correlated
-5.51%
CTMX - NRXS
25%
Poorly correlated
-8.70%
PCVX - NRXS
25%
Poorly correlated
-3.05%
TSHA - NRXS
24%
Poorly correlated
-5.03%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with VIR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-3.05%
VIR - PCVX
52%
Loosely correlated
-3.21%
NUVL - PCVX
51%
Loosely correlated
-1.78%
DNLI - PCVX
48%
Loosely correlated
-5.14%
BCYC - PCVX
47%
Loosely correlated
-5.08%
AVBP - PCVX
45%
Loosely correlated
-2.41%
More